Posts found in:

Healthcare & Life Science

What Every First-Time Entrepreneur Should Know About When to Use a Corporate Lawyer Image

What Every First-Time Entrepreneur Should Know About When to Use a Corporate Lawyer

Founding a company is a time-consuming and expensive endeavor, and you’re probably not thinking about a corporate lawyer when time and resources are everything. Company founders are forced to decide how to spend limited dollars between significant competing priorities. In many cases, early stage companies either underinvest in legal expertise…

New Year, New Vacation Policy? What Colorado Employers Need to Know Image

New Year, New Vacation Policy? What Colorado Employers Need to Know

In a tight labor market, it’s often the benefits and perks that help employers compete for talent. One key benefit an employer must consider is vacation. Should vacation be offered, and if so, how much and how should it be structured? What’s the real value of vacation to employees and…

How Emerging Companies Can Negotiate Better Life Sciences Commercial Contracts Image

How Emerging Companies Can Negotiate Better Life Sciences Commercial Contracts

Most life sciences companies negotiate numerous commercial contracts each year and must rely on big industry players for essential testing, supply and manufacturing partnerships. But these relationships can feel very unbalanced because large vendors seem to have far more negotiating power than any emerging company. Less favorable terms can have…

KO Client Onward Raises $1.5 Million in Seed Funding  Image

KO Client Onward Raises $1.5 Million in Seed Funding 

KO client Onward, which offers round-trip, door-to-door rides for older adults who need assistance, has raised $1.5 million in seed funding from Royal Street Ventures, Matchstick Ventures and JPK Capital. KO partner Kevin Gibson and attorney Elizabeth Ho represented Onward in the financing. Read more in TechCrunch.

Why Emerging Life Science And Pharma Companies Should Apply The CRO Model To Commercial Contracts Image

Why Emerging Life Science And Pharma Companies Should Apply The CRO Model To Commercial Contracts

2019 is off to a fast start in the life science, pharmaceutical and medical device industries with unprecedented market growth. Life sciences, in particular, continue on an upward trend, accounting for nearly 15 percent of venture deal flow in 2018, more than 60 percent of which were deals of $50…